The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBenchmark Holdings Regulatory News (BMK)

Share Price Information for Benchmark Holdings (BMK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 44.60
Bid: 44.50
Ask: 45.00
Change: -0.40 (-0.89%)
Spread: 0.50 (1.124%)
Open: 44.60
High: 44.60
Low: 44.60
Prev. Close: 45.00
BMK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director Dealings

24 Jan 2018 13:01

RNS Number : 8157C
Benchmark Holdings PLC
24 January 2018
 

24 January 2018

BENCHMARK HOLDINGS PLC("Benchmark" or the "Company" or the "Group")

DIRECTOR DEALINGS

 

The Company has been informed that Kevin Quinn, Non-Executive Director of the Company, purchased 35,929 ordinary shares of 0.1 pence each in Benchmark ("Ordinary Shares") at a price of 69.55 pence per share on 23 January 2018. 

Following this transaction, Kevin's total beneficial interest in the Company is 60,929 ordinary shares, representing approximately 0.01 per cent. of the Company's issued share capital.

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

Notification and public disclosure of a transaction by a person discharging managerial responsibilities.

 1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Kevin Quinn

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Non-Executive Director

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Benchmark Holdings plc

b)

 

LEI

 

 

n/a

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Identification code

 

0.1p ordinary shares

 

ISIN: GB00BGHPT808

b)

 

Nature of the transaction

 

 

Purchase of shares

 

c)

 

Price(s) and volume(s)

 

 

Price(s)

 

Volume(s)

69.55p 

35,929

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

- Aggregated total

 

 

 

35,929

 

69.55p

 

£24,988.62

e)

 

Date of the transaction

 

23 January 2018

f)

 

Place of the transaction

 

 

London Stock Exchange, AIM

 

 

-Ends-

Benchmark Holdings plc

Tel: 020 7920 3150

Malcolm Pye, CEO

Ivonne Cantu, Investor Relations Director

Rachel Aninakwah, Communications

Numis

Tel: 020 7260 1000

Michael Meade / Freddie Barnfield (NOMAD)

James Black (Corporate Broking)

MHP

Katie Hunt / Reg Hoare /Alistair de Kare-Silver

Tel: 020 3128 8742 07551 170 451

benchmark@mhpc.com

 

Notes to Editors:

Benchmark challenges the status quo in aquaculture. Since 2000, Benchmark has consistently worked to build a technology-rich platform in the areas of genetics, nutrition, animal health and knowledge services, to serve its customers, helping them take control of their biological environment to improve yield and efficiency in a sustainable way.

The Company has leading positions in its core markets and established R&D, manufacturing and distribution capabilities to serve all the major aquaculture markets. Benchmark operates in 27 countries in five continents and as at 30 September 2017, it employed 950 people. 

For further information on Benchmark please visit www.benchmarkplc.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHLZLFLVFFEBBK
Date   Source Headline
10th Mar 201610:13 amRNSResult of AGM
5th Feb 20162:51 pmRNSDirector Dealings
2nd Feb 20167:00 amRNSFinal Results
7th Jan 201611:02 amRNSHolding(s) in Company
5th Jan 201612:08 pmRNSHolding(s) in Company
4th Jan 20163:04 pmRNSHolding(s) in Company
4th Jan 20163:00 pmRNSHolding(s) in Company
4th Jan 201611:18 amRNSHolding(s) in Company
4th Jan 201610:47 amRNSHolding(s) in Company
4th Jan 201610:43 amRNSHolding(s) in Company
4th Jan 201610:40 amRNSHolding(s) in Company
4th Jan 20169:26 amRNSHolding(s) in Company
4th Jan 20169:19 amRNSHolding(s) in Company
31st Dec 20157:00 amRNSFurther admission of shares
29th Dec 201511:43 amRNSResult of General Meeting
14th Dec 201511:00 amRNSSchedule 1 - Benchmark Holdings plc
14th Dec 20157:30 amRNSRestoration - Benchmark Holdings plc
14th Dec 20157:00 amRNSPlacing and Acquisition
9th Nov 20157:00 amRNSCanine Vaccine Licensing Deal Secured
6th Nov 201511:28 amRNSResponse to Lumpfish VHS
8th Oct 20152:43 pmRNSFurther re. potential acquisition
8th Oct 201512:15 pmRNSPotential acquisition and suspension of shares
8th Oct 201512:15 pmRNSSuspension - Benchmark Holdings Plc
30th Sep 20157:00 amRNSSalmoBreed breakthrough
30th Sep 20157:00 amRNSTotal Voting Rights
16th Sep 20157:00 amRNSBlock Admission Application
27th Jul 20157:00 amRNSAcquisition
13th Jul 20153:40 pmRNSHolding(s) in Company
23rd Jun 20157:00 amRNSHalf Yearly Report
6th May 20155:46 pmRNSHolding(s) in Company
30th Apr 201512:44 pmRNSHolding(s) in Company
29th Apr 20157:00 amRNSTrading Statement
23rd Apr 201512:34 pmRNSHolding(s) in Company
17th Mar 201512:25 pmRNSHolding(s) in Company
10th Mar 20151:13 pmRNSDirector Share Options
5th Mar 201510:43 amRNSResult of AGM
26th Feb 20152:39 pmRNSHolding(s) in Company
16th Feb 20151:51 pmRNSHolding(s) in Company
3rd Feb 201512:59 pmRNSHolding(s) in Company
2nd Feb 20157:00 amRNSAcquisition
27th Jan 20157:01 amRNSFinal Results
8th Jan 20152:21 pmRNSHolding(s) in Company
6th Jan 201510:53 amRNSHolding(s) in Company
19th Dec 20144:32 pmRNSHolding(s) in Company
19th Dec 20144:26 pmRNSHolding(s) in Company
19th Dec 20144:24 pmRNSHolding(s) in Company
19th Dec 20144:20 pmRNSHolding(s) in Company
19th Dec 20144:14 pmRNSHolding(s) in Company
18th Dec 20144:38 pmRNSResult of General Meeting
10th Dec 201412:44 pmRNSProposed Placing and Acquisitions Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.